Accrued Liabilities - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.28 USD 5.42%
Market Cap: 448.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MaxCyte Inc
Accrued Liabilities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Accrued Liabilities
$12m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Accrued Liabilities
$4.5B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Accrued Liabilities
$2.8B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Accrued Liabilities
$338.3m
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accrued Liabilities
$573m
CAGR 3-Years
-8%
CAGR 5-Years
5%
CAGR 10-Years
-2%
IQVIA Holdings Inc
NYSE:IQV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MaxCyte Inc's Accrued Liabilities?
Accrued Liabilities
12m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Accrued Liabilities amounts to 12m USD.

What is MaxCyte Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
27%

Over the last year, the Accrued Liabilities growth was 47%. The average annual Accrued Liabilities growth rates for MaxCyte Inc have been 27% over the past three years .

Back to Top